证券记录 · 已归档季度
ASND
Ascendis Pharma A/S · Healthcare · Biotechnology
12被追踪持有人
-2Δ持有人
9.16M持有股份
$1.58B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -14.3% ·
股份流向 -12.6% ·
净新建仓位 -16.7%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | +15 | 28.56M | $7.62B | +25 | −10 |
| Q1 2026 | 92 | -6 | 28.38M | $6.48B | +8 | −14 |
| Q4 2025 | 96 | -1 | 34.58M | $7.37B | — | −1 |
| Q3 2025 | 15 | 0 | 10.69M | $2.13B | +1 | −1 |
| Q2 2025 | 12 | -2 | 9.16M | $1.58B | — | −2 |
| Q1 2025 | 12 | +1 | 5.48M | $853.40M | +1 | — |
| Q4 2024 | 11 | -2 | 5.30M | $729.95M | — | −2 |
| Q3 2024 | 12 | +1 | 6.24M | $930.97M | +2 | −1 |
| Q2 2024 | 11 | — | 7.02M | $958.03M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.88M | -16.9% | $323.71M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 587.34K | -47.8% | $101.38M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 587.34K | -47.8% | $101.38M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (被动) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Adage Capital Partners ✦ | 459.61K | +40.4% | $79.33M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 29 | Marshall Wace ✦ | 117.16K | +425.5% | $20.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Marshall Wace ✦ | 117.16K | +425.5% | $20.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Marshall Wace ✦ | 117.16K | +425.5% | $20.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Millennium Management ✦ | 72.89K | -72.5% | $12.58M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Geode Capital Management ✦ (被动) | 60.80K | +5.1% | $10.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | State Street Global Advisors ✦ (被动) | 58.20K | -12.8% | $10.05M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 35 | D. E. Shaw & Co. ✦ | 7.19K | -65.0% | $1.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 3.12K | -83.4% | $537,649 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Point72 Asset Management | $88.71M | 曾为 0.3% |
| Duquesne Family Office | $24.74M | 曾为 0.8% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 8 持有人, 7.94M 股份, $34.76M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 14
BIENAIME JEAN JACQUES
Director · 1.10K 股 @ 245.85 · $270,435
Aug 14
BIENAIME JEAN JACQUES
Director · 900 股 @ 246.91 · $222,219
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A — Artisan Partners Limited Partnership
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据